Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:715-722

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LaPointe, M. C.
Right arrow Articles by Gardner, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LaPointe, M. C.
Right arrow Articles by Gardner, D. G.

(Hypertension. 1996;27:715-722.)
© 1996 American Heart Association, Inc.


Articles

Tissue-Specific Expression of the Human Brain Natriuretic Peptide Gene in Cardiac Myocytes

Margot C. LaPointe; Guiyun Wu; Miklós Garami; Xiao-Ping Yang; David G. Gardner

From the Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, Mich (M.C.L., G.W., X.-P.Y.), and Metabolic Research Unit, University of California, San Francisco (M.G., D.G.G.).

Correspondence to Dr Margot C. LaPointe, Hypertension and Vascular Research Division, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202-2689. E-mail mclapointe@aol.com.

Abstract Brain natriuretic peptide (BNP) is a cardiac hormone constitutively expressed in the adult heart. To identify the cis-acting elements involved in regulation of the human BNP gene, we subcloned the full-length promoter (-1818 to +100) and deletions thereof upstream from a luciferase reporter gene and transiently transfected them into primary cultures of neonatal rat atrial and ventricular myocytes and myocardial fibroblasts. Luciferase activity of the full-length construct was higher in ventricular (39 064±8488 relative light units, n=11) and atrial (11 225±1907, n=17) myocytes than myocardial fibroblasts (329±113, n=5). Maximal promoter activity in ventricular and atrial myocytes was maintained by sequences positioned between -1818 and -1283 relative to the transcription start site. Deletion to -1175 resulted in a decrease, whereas further deletion to -500 effected an increase in reporter activity in both cell types. In ventricular and atrial myocytes, deletion from -500 to -40 reduced luciferase activity 20-fold and 2-fold, respectively, whereas in myocardial fibroblasts, deletion to -40 upregulated the BNP promoter 2-fold. Of note, deleting 16 bp between -127 and -111 reduced luciferase activity 7-fold and 4-fold in ventricular and atrial myocytes, respectively, but had essentially no effect on luciferase activity in fibroblasts. Placement of sequences lying between -127 and -40 upstream from a heterologous thymidine kinase promoter resulted in reporter expression that was 7.4-fold greater than the vector alone in ventricular myocytes, approximately 2-fold greater in atrial myocytes, and equivalent to the vector alone in fibroblasts. For study of activity of the human BNP promoter in adult myocytes, either 408 or 97 bp of 5' flanking sequence coupled to the luciferase reporter gene was injected into the apex of adult male Sprague-Dawley rat hearts. After 7 days, luciferase activity in the injected myocardium was 9.8-fold higher for the longer construct (70 683±14 744 versus 7223±3920, n=4, P<.01), consistent with our in vitro data. These data indicate that (1) the full-length human BNP promoter is more active in ventricular versus atrial myocytes and essentially inactive in fibroblasts, (2) the distal BNP promoter contains both positive and negative regulatory elements, (3) a region of the proximal BNP promoter located between -127 and -40 confers tissue specificity, and (4) the BNP promoter is active after injection into the adult rat heart.


Key Words: heart cells • natriuretic factor, brain • peptides • gene regulation




This article has been cited by other articles:


Home page
Clin. Chem.Home page
C. Vassalle and M. G. Andreassi
Genetic Polymorphisms of the Natriuretic Peptide System in the Pathogenesis of Cardiovascular Disease: What Lies on the Horizon?
Clin. Chem., May 1, 2009; 55(5): 878 - 887.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. J. Glenn, F. Wang, S. Chen, M. Nishimoto, and D. G. Gardner
Endothelin-Stimulated Human B-Type Natriuretic Peptide Gene Expression Is Mediated by Yin Yang 1 in Association With Histone Deacetylase 2
Hypertension, March 1, 2009; 53(3): 549 - 555.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Chen, D. J. Glenn, W. Ni, C. L. Grigsby, K. Olsen, M. Nishimoto, C. S. Law, and D. G. Gardner
Expression of the Vitamin D Receptor Is Increased in the Hypertrophic Heart
Hypertension, December 1, 2008; 52(6): 1106 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. M. Heidrich, K. Zhang, M. Estrada, Y. Huang, F. J. Giordano, and B. E. Ehrlich
Chromogranin B Regulates Calcium Signaling, Nuclear Factor {kappa}B Activity, and Brain Natriuretic Peptide Production in Cardiomyocytes
Circ. Res., May 23, 2008; 102(10): 1230 - 1238.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. G. Gardner, S. Chen, D. J. Glenn, and C. L. Grigsby
Molecular Biology of the Natriuretic Peptide System: Implications for Physiology and Hypertension
Hypertension, March 1, 2007; 49(3): 419 - 426.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Luo, C. Jiang, A. J. Belanger, G. Y. Akita, S. C. Wadsworth, R. J. Gregory, and K. A. Vincent
A Constitutively Active Hypoxia-Inducible Factor-1{alpha}/VP16 Hybrid Factor Activates Expression of the Human B-Type Natriuretic Peptide Gene
Mol. Pharmacol., June 1, 2006; 69(6): 1953 - 1962.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-Y. Qian, A. Leung, P. Harding, and M. C. LaPointe
PGE2 stimulates human brain natriuretic peptide expression via EP4 and p42/44 MAPK
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1740 - H1746.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Mendez and M. C. LaPointe
PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2111 - H2117.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. D. I. Anderson, F. Wang, and D. G. Gardner
Role of the Epidermal Growth Factor Receptor in Signaling Strain-dependent Activation of the Brain Natriuretic Peptide Gene
J. Biol. Chem., March 5, 2004; 279(10): 9287 - 9297.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Mendez and M. C. LaPointe
PPAR{gamma} Inhibition of Cyclooxygenase-2, PGE2 Synthase, and Inducible Nitric Oxide Synthase in Cardiac Myocytes
Hypertension, October 1, 2003; 42(4): 844 - 850.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Liang, F. Wang, S. Zhang, and D. G. Gardner
Peroxisome Proliferator Activated Receptor (PPAR){alpha} Agonists Inhibit Hypertrophy of Neonatal Rat Cardiac Myocytes
Endocrinology, September 1, 2003; 144(9): 4187 - 4194.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Liang, P. Webb, A. Marimuthu, S. Zhang, and D. G. Gardner
Triiodothyronine Increases Brain Natriuretic Peptide (BNP) Gene Transcription and Amplifies Endothelin-dependent BNP Gene Transcription and Hypertrophy in Neonatal Rat Ventricular Myocytes
J. Biol. Chem., April 18, 2003; 278(17): 15073 - 15083.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. C. LaPointe, X.-P. Yang, O. A. Carretero, and Q. He
Left ventricular targeting of reporter gene expression in vivo by human BNP promoter in an adenoviral vector
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1439 - H1445.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Q. He, M. Mendez, and M. C. LaPointe
Regulation of the human brain natriuretic peptide gene by GATA-4
Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E50 - E57.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Ogawa, Y. Saito, K. Kuwahara, M. Harada, Y. Miyamoto, I. Hamanaka, N. Kajiyama, N. Takahashi, T. Izumi, R. Kawakami, et al.
Fibronectin signaling stimulates BNP gene transcription by inhibiting neuron-restrictive silencer element-dependent repression
Cardiovasc Res, February 1, 2002; 53(2): 451 - 459.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. C Kone
Molecular biology of natriuretic peptides and nitric oxide synthases
Cardiovasc Res, August 15, 2001; 51(3): 429 - 441.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Q. He and M. C. LaPointe
Src and Rac Mediate Endothelin-1 and Lysophosphatidic Acid Stimulation of the Human Brain Natriuretic Peptide Promoter
Hypertension, February 1, 2001; 37(2): 478 - 484.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. He, D. Wang, X.-P. Yang, O. A. Carretero, and M. C. LaPointe
Inducible regulation of human brain natriuretic peptide promoter in transgenic mice
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H368 - H376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Q. He, G. Wu, and M. C. Lapointe
Isoproterenol and cAMP regulation of the human brain natriuretic peptide gene involves Src and Rac
Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1115 - E1123.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Liang, S. Lu, and D. G. Gardner
Endothelin-Dependent and -Independent Components of Strain-Activated Brain Natriuretic Peptide Gene Transcription Require Extracellular Signal Regulated Kinase and p38 Mitogen-Activated Protein Kinase
Hypertension, January 1, 2000; 35(1): 188 - 192.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Q. He and M. C. LaPointe
Interleukin-1{beta} Regulates the Human Brain Natriuretic Peptide Promoter via Ca2+-Dependent Protein Kinase Pathways
Hypertension, January 1, 2000; 35(1): 292 - 296.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Chen, M. Garami, and D. G. Gardner
Doxorubicin Selectively Inhibits Brain Versus Atrial Natriuretic Peptide Gene Expression in Cultured Neonatal Rat Myocytes
Hypertension, December 1, 1999; 34(6): 1223 - 1231.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Q. He and M. C. LaPointe
Interleukin-1ß Regulation of the Human Brain Natriuretic Peptide Promoter Involves Ras-, Rac-, and p38 Kinase–Dependent Pathways in Cardiac Myocytes
Hypertension, January 1, 1999; 33(1): 283 - 289.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Liang and D. G. Gardner
Autocrine/Paracrine Determinants of Strain-activated Brain Natriuretic Peptide Gene Expression in Cultured Cardiac Myocytes
J. Biol. Chem., June 5, 1998; 273(23): 14612 - 14619.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Liang, J. Wu, M. Garami, and D. G. Gardner
Mechanical Strain Increases Expression of the Brain Natriuretic Peptide Gene in Rat Cardiac Myocytes
J. Biol. Chem., October 31, 1997; 272(44): 28050 - 28056.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
D. Zechner, D. J. Thuerauf, D. S. Hanford, P. M. McDonough, and C. C. Glembotski
A Role for the p38 Mitogen-activated Protein Kinase Pathway in Myocardial Cell Growth, Sarcomeric Organization, and Cardiac-specific Gene Expression
J. Cell Biol., October 6, 1997; 139(1): 115 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Methot, M. C. LaPointe, R. M. Touyz, X.-P. Yang, O. A. Carretero, C. F. Deschepper, E. L. Schiffrin, G. Thibault, and T. L. Reudelhuber
Tissue Targeting of Angiotensin Peptides
J. Biol. Chem., May 16, 1997; 272(20): 12994 - 12999.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Thuerauf and C. C. Glembotski
Differential Effects of Protein Kinase C, Ras, and Raf-1 Kinase on the Induction of the Cardiac B-type Natriuretic Peptide Gene through a Critical Promoter-proximal M-CAT Element
J. Biol. Chem., March 14, 1997; 272(11): 7464 - 7472.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Liang, A. Atakilit, and D. G. Gardner
Integrin Dependence of Brain Natriuretic Peptide Gene Promoter Activation by Mechanical Strain
J. Biol. Chem., June 30, 2000; 275(27): 20355 - 20360.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. E. Hoover, D. J. Thuerauf, J. J. Martindale, and C. C. Glembotski
alpha B-crystallin Gene Induction and Phosphorylation by MKK6-activated p38. A POTENTIAL ROLE FOR alpha B-CRYSTALLIN AS A TARGET OF THE p38 BRANCH OF THE CARDIAC STRESS RESPONSE
J. Biol. Chem., July 28, 2000; 275(31): 23825 - 23833.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Craig, A. Larkin, A. M. Mingo, D. J. Thuerauf, C. Andrews, P. M. McDonough, and C. C. Glembotski
p38 MAPK and NF-kappa B Collaborate to Induce Interleukin-6 Gene Expression and Release. EVIDENCE FOR A CYTOPROTECTIVE AUTOCRINE SIGNALING PATHWAY IN A CARDIAC MYOCYTE MODEL SYSTEM
J. Biol. Chem., July 28, 2000; 275(31): 23814 - 23824.
[Abstract] [Full Text] [PDF]